Basics BeiGene, Ltd. American Depositary Shares IPO Date: July 25, 2013 Sector: Healthcare Industry: Biotech Market Cap: $26.6B Activated in VL: True Average Daily Range Avg Daily Range: $3.79 | 1.61% Avg Daily Range (30 D): $3.19 | 1.31% Avg Daily Range (90 D): $3.76 | 1.54% Institutional Daily Volume Avg Daily Volume: .01M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 40 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 40 Institutional Trades Total Inst.Trades: 218 Avg Inst. Trade: $6.71M Avg Inst. Trade (30 D): $7.21M Avg Inst. Trade (90 D): $6.92M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $7.03M Avg Closing Trade (30 D): $6.78M Avg Closing Trade (90 D): $7.47M Avg Closing Volume: 29.08K     News May 30, 2025 @ 10:00 AM Zymeworks Announces NMPA Approval of Zanidatamab i... Source: N/A May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Apr 23, 2025 @ 8:05 PM Why Summit Therapeutics Rocketed Double-Digits Tod... Source: Billy Duberstein Apr 17, 2025 @ 10:00 AM Zymeworks to Report First Quarter 2025 Financial R... Source: N/A Apr 3, 2025 @ 3:19 PM BeiGene Discontinues Lung Cancer Drug Study After ... Source: Vandana Singh Financials   TTM N/A N/A Basic EPS $ Diluted EPS $ Revenue $ 1.12B $ $ Gross Profit $ 952.28M $ $ Net Income / Loss $ 1.27M $ $ Operating Income / Loss $ 11.1M $ $ Cost of Revenue $ 165M $ $ Net Cash Flow $ -108.16M $ $ PE Ratio